KLA Corporation Work in process decreased by 2.7% to $836.17M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $768.13M to $836.17M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 16.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $453.43M | $426.86M | $427.97M | $441.56M | $451.78M | $527.36M | $477.59M | $575.08M | $578.86M | $635.05M | $621.41M | $674.19M | $700.90M | $736.88M | $768.13M | $808.56M | $833.93M | $859.78M | $836.17M |
| QoQ Change | — | -5.9% | +0.3% | +3.2% | +2.3% | +16.7% | -9.4% | +20.4% | +0.7% | +9.7% | -2.1% | +8.5% | +4.0% | +5.1% | +4.2% | +5.3% | +3.1% | +3.1% | -2.7% |
| YoY Change | — | — | — | — | -0.4% | +23.5% | +11.6% | +30.2% | +28.1% | +20.4% | +30.1% | +17.2% | +21.1% | +16.0% | +23.6% | +19.9% | +19.0% | +16.7% | +8.9% |
| % of Inventories | 129.6% | 122.3% | 115.3% | 112.3% | 112.3% | 124.7% | 105.4% | 116.7% | 110.4% | 113.4% | 106.0% | 113.3% | 118.8% | 122.4% | 131.1% | 138.0% | 138.8% | 141.4% | 133.7% |
| Share Change | — | -7.3pp | -7.1pp | -3.0pp | +0.1pp | +12.3pp | -19.3pp | +11.3pp | -6.3pp | +2.9pp | -7.4pp | +7.3pp | +5.5pp | +3.5pp | +8.7pp | +6.9pp | +0.8pp | +2.6pp | -7.7pp |
We use cookies for analytics. See our Privacy and Cookie Policy.